FK-506 (tacrolimus) therapy for an unusual SLE-like disease.
Kilian
K
K
Department of Bone Marrow Transplantation and Immunotherapy, National Institute of Haematology and Immunology, Budapest, Hungary.
Banyai
A
A
Karadi
A
A
Miklos
K
K
Patranyi
G G
GG
Paloczi
K
K
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus